Show simple item record

dc.coverage.spatialMedicinaspa
dc.creatorUribe Vargas, Simon
dc.creatorSierra Suarez, Diego Fernando
dc.date.accessioned2019-12-24T17:09:41Z
dc.date.accessioned2019-12-30T19:05:30Z
dc.date.available2019-12-24T17:09:41Z
dc.date.available2019-12-30T19:05:30Z
dc.date.created2019-11-06
dc.identifier.urihttp://hdl.handle.net/10654/32929
dc.description.abstractObjetivo: Describir los resultados refractivos y complicaciones de los pacientes a los que se les realizó implante de lente intraocular fáquico retroiridiano en el Hospital Militar Central, Bogotá-Colombia durante el periodo 2015-2018. Métodos: Este artículo fue diseñado como un estudio tipo serie de casos, donde se valoraron los ojos que tenían implante lente intraocular fáquico retroiridiano ICL V4c para la corrección de la miopía moderada a alta. La agudeza visual sin corrección (AVSC) y con corrección (AVCC), refracción, presión intraocular (PIO), densidad de células endoteliales y complicaciones, fueron evaluados durante 6 meses. Resultados: El estudio incluyó 46 ojos de 27 pacientes. El equivalente esférico (EE) promedio fue: -7,33 0,66DP, tras 6 meses postquirúrgicos el EE mejoro a -0,3110DP, con el 83% de ojos dentro del rango  0.50DP de objetivo refractivo y el 100% de ojos dentro de 1.00 DP. La AVSC promedio fue: 0,17 0,03 logMAR. Los índices de eficacia y seguridad fueron:0,68 y 0,82 respectivamente. En ningún caso hubo perdida de líneas de visión durante el seguimiento. La PIO se mantuvo estable en el tiempo, no se presentaron cataratas u opacidad del cristalino y la pérdida de células endoteliales fue del 0,2% tras 6 meses de seguimiento. CONCLUSIÓN: Los resultados tras el implante de este nuevo tipo de lente respecto a todos los parámetros tomados en cuenta han sido promisorios, lo cual siguiere el uso del lente ICL V4c como una alternativa viable para el manejo de la miopía moderada- alta en Colombia. Palabras clave: Phakic Intraocular Lens, central hole, implantable collamer lens, myopia, Colombia.spa
dc.description.tableofcontents1.Introduccion 2.Metodologia 3.Resultados 4.Discusion 5.Conclusiones 6.Bibliografiaspa
dc.formatpdfspa
dc.format.mimetypeapplication/pdfspa
dc.languagespaspa
dc.language.isospaspa
dc.publisherUniversidad Militar Nueva Granadaspa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.5/co/spa
dc.subjectlente intraocular faquicospa
dc.subjectpuerto centralspa
dc.subjectlente de colamero implantablespa
dc.subjectmiopiaspa
dc.subjectcolombiaspa
dc.subject.meshOFTALMOLOGIAspa
dc.subject.meshIMPLANTES ARTIFICIALESspa
dc.subject.meshLENTES INTRAOCULARESspa
dc.subject.meshLENTES OFTALMICOSspa
dc.titleExperiencia en implante de lentes intraoculares fáquicos retroiridianos en el Hospital Militar Central de Bogotá, Colombia durante el período 2015-2018spa
dc.typeinfo:eu-repo/semantics/bachelorThesisspa
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessspa
dc.publisher.departmentFacultad de Medicinaspa
dc.type.spaTrabajo de gradospa
dc.creator.emailuribe_simon@hotmail.comspa
dc.creator.emaildiego.sierra@hospitalmilitar.gov.cospa
dc.description.abstractenglishAIM: Describe the refractive results and complications of patients who underwent phakic intraocular lens implantation at the Central Military Hospital, Bogota-Colombia during the 2015-2018 period. Methods: This article was designed as a case series study, where the eyes that had ICL V4c phakic intraocular lens implant for the correction of moderate to high myopia were evaluated. Undercorrected distance (UDVA) and corrected (CDVA) visual acuity, refraction, intraocular pressure (IOP), endothelial cell density and adverse events were evaluated at 6 months. Results: The study included 46 eyes of 27 patients. The mean spherical equivalent (EE) was: -7.33  0.66DP, 6 months after surgery the EE was -0.31  10DP, with 83% of eyes within the range of 0.50 DP for refractive objective and 100% of eyes within  1.00 DP. The mean AVSC was: 0.17  0.03logMAR. The efficacy and safety indices were: 0.68 and 0.82 respectively. In no case there was loss of visual acuity lines during the follow-up. The IOP remained stable over time, there were no cataracts or opacity of the lens and the loss of endothelial cells was 0.2% after 6 months of follow-up. CONCLUSIONS: Good results were obtained in UDVA, refraction and stable intraocular pressures during follow-up, which suggest the use of the ICL V4c lens as an alternative for the management of moderate-high myopia in Colombia for patients in whom refractive surgery with laser excimer cannot be performed.spa
dc.title.titleenglishImplant experience of posterior chamber phakic intraocular lenses in the Central Military Hospital of Bogotá, Colombia during the period 2015-2018spa
dc.subject.keywordPhakic Intraocular Lensspa
dc.subject.keywordcentral holespa
dc.subject.keywordimplantable collamer lensspa
dc.subject.keywordmyopiaspa
dc.subject.keywordColombiaspa
dc.publisher.programOftalmologíaspa
dc.creator.degreeEspecialista en Oftalmologíaspa
dc.source.bibliographicCitationMiao H, Chen X, Tian M, Chen Y, Wang X, Zhou X. Refractive outcomes and optical quality after implantation of posterior chamber phakic implantable collamer lens with a central hole (ICL V4c). BMC Ophthalmol. 2018;18(1):1–7.spa
dc.source.bibliographicCitationGalvis V, Tello A, Camacho PA, Parra MM, Merayo-Lloves J. Los factores bioambientales asociados a la miopía: una revisión actualizada. Arch Soc Esp Oftalmol [Internet]. 2017;92(7):307–25. Available from: http://dx.doi.org/10.1016/j.oftal.2016.11.016spa
dc.source.bibliographicCitationWalline JJ. Myopia control: A review. Eye Contact Lens. 2016;42(1):3–8.spa
dc.source.bibliographicCitationMalecaze F, Porterie M, Cassagne M. Phakic intraocular lenses. Cataract. 2013;50(6):80–99.spa
dc.source.bibliographicCitationHug TE. Myopia. Pract Manag Pediatr Ocul Disord Strabismus A Case-based Approach. 2016;379:45–9.spa
dc.source.bibliographicCitationBrenner LF, Alió JL, Vega-Estrada A, Baviera J, Beltrán J, Cobo-Soriano R. Clinical grading of post-LASIK ectasia related to visual limitation and predictive factors for vision loss. J Cataract Refract Surg. 2012;38(10):1817–26.spa
dc.source.bibliographicCitationAlfonso JF, Lisa C, Fernández-Vega L, Almanzar D, Pérez-Vives C, Montés-Micó R. Prevalence of cataract after collagen copolymer phakic intraocular lens implantation for myopia, hyperopia, and astigmatism. J Cataract Refract Surg. 2015;41(4):800–5.spa
dc.source.bibliographicCitationHigueras-Esteban A, Ortiz-Gomariz A, Gutiérrez-Ortega R, Villa-Collar C, Abad-Montes JP, Fernandes P, et al. Intraocular pressure after implantation of the Visian implantable Collamer lens with CentraFLOW without iridotomy. Am J Ophthalmol. 2013;156(4):800–6.spa
dc.source.bibliographicCitationGonzalez-Lopez F, Bilbao-Calabuig R, Mompean B, De Rojas V, Luezas J, Djodeyre MR, et al. Intraocular pressure during the early postoperative period after 100 consecutive implantations of posterior chamber phakic intraocular lenses with a central hole. J Cataract Refract Surg [Internet]. 2013;39(12):1859–63. Available from: http://dx.doi.org/10.1016/j.jcrs.2013.06.020spa
dc.source.bibliographicCitationDejaco-Ruhswurm I, Scholz U, Pieh S, Hanselmayer G, Lackner B, Italon C, et al. Long-term endothelial changes in phakic eyes with posterior chamber intraocular lenses. J Cataract Refract Surg. 2002;28(9):1589–93.spa
dc.source.bibliographicCitationPacker M. Meta-analysis and review: Effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059–77.spa
dc.source.bibliographicCitationPacker M. The implantable collamer lens with a central port: Review of the literature. Clin Ophthalmol. 2018;12:2427–38.spa
dc.source.bibliographicCitationVisian ICL (Implantable Collamer Lens) for Myopia: Directions for Use. STAAR Surgical. Available from: http://staar.com/file/ PKG-02012_Rev_2_DFU-for-MICL-Visian-ICL.pdf. Accessed April 3 2018. Visian ICL (Implantable Collamer Lens) for Myopia: Directions for Use. STAAR Surgical. Available from: http://staar.com/file/ PKG-02012_Rev_2_DFU-for-MICL-Visian-ICL.pdf. Accessed April 3, 2018.spa
dc.source.bibliographicCitationLisa C, Naveiras M, Alfonso-Bartolozzi B, Belda-Salmerón L, Montés-Micó R, Alfonso JF. Posterior chamber collagen copolymer phakic intraocular lens with a central hole to correct myopia: One-year follow-up. J Cataract Refract Surg. 2015;41(6):1153–9.spa
dc.source.bibliographicCitationUnited States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: Three-year follow-up. Ophthalmology. 2004;111(9):1683–92.spa
dc.source.bibliographicCitationSTAAR Surgical Announces Approval By Health Canada of Its EVO Visian ICL for Surgeons and Their Patients in Canada. http://phx.corporate-ir.net/phoenix.zhtml?c=71327&p=irol-newsArticle_print&ID=2168212. Accessed August 1, 2016. 1. STAAR Surgical Announces Approval By Health Canada of Its EVO Visian ICL for Surgeons and Their Patients in Canada. http://phx.corporate-ir.net/phoenix.zhtml?c=71327&p=irol-newsArticle_print&ID=2168212. Accessed August 1, 2016.spa
dc.source.bibliographicCitationPineda R, Chauhan T. Phakic intraocular lenses and their special indications. J Ophthalmic Vis Res. 2016;11(4):422–8.spa
dc.source.bibliographicCitationCao X, Wang Y, Xie C, Tong J, Shen Y, Wu W. Posterior chamber collagen copolymer phakic intraocular lens with a central hole for moderate-to-high myopia First experience in China. Med (United States). 2016;95(36):4–9.spa
dc.source.bibliographicCitationAlfonso JF, Lisa C, Fernández-Vega Cueto L, Belda-Salmerón L, Madrid-Costa D, Montés-Micó R. Clinical outcomes after implantation of a posterior chamber collagen copolymer phakic intraocular lens with a central hole for myopic correction. J Cataract Refract Surg. 2013;39(6):915–21.spa
dc.source.bibliographicCitationShimizu K, Kamiya K, Igarashi A, Shiratani T. Early clinical outcomes of implantation of posterior chamber phakic intraocular lens with a central hole (Hole ICL) for moderate to high myopia. Br J Ophthalmol. 2012;96(3):409–12.spa
dc.source.bibliographicCitationKamiya K, Shimizu K, Kobashi H, Igarashi A, Komatsu M, Nakamura A, et al. Three-year follow-up of posterior chamber toric phakic intraocular lens implantation for the correction of high myopic astigmatism in eyes with keratoconus. Br J Ophthalmol. 2015;99(2):177–83.spa
dc.source.bibliographicCitationKamiya K, Shimizu K, Saito A, Igarashi A, Kobashi H. Comparison of Optical Quality and Intraocular Scattering after Posterior Chamber Phakic Intraocular Lens with and without a Central Hole (Hole ICL and Conventional ICL) Implantation Using the Double-Pass Instrument. PLoS One. 2013;8(6):1–5.spa
dc.source.bibliographicCitationKamiya K, Shimizu K, Igarashi A, Kitazawa Y, Kojima T, Nakamura T, et al. Posterior chamber phakic intraocular lens implantation: Comparative, multicentre study in 351 eyes with low-to-moderate or high myopia. Br J Ophthalmol. 2018;102(2):177–81.spa
dc.source.bibliographicCitationShimizu K, Kamiya K, Igarashi A, Shiratani T. Intraindividual comparison of visual performance after posterior chamber phakic intraocular lens with and without a central hole implantation for moderate to high myopia. Am J Ophthalmol [Internet]. 2012;154(3):486-494.e1. Available from: http://dx.doi.org/10.1016/j.ajo.2012.04.001spa
dc.source.bibliographicCitationIcl V. The New EVO + Evolution in Visual Freedom The New EVO Visian ICL Evolution in Visual Freedom. 2016;(September).spa
dc.source.bibliographicCitationShiratani T, Shimizu K, Fujisawa K, Uga S, Nagano K, Murakami Y. Crystalline lens changes in porcine eyes with implanted phakic IOL (ICL) with a central hole. Graefe’s Arch Clin Exp Ophthalmol. 2008;246(5):719–28.spa
dc.source.bibliographicCitationLu Y, Yang N, Li X, Kong J. Four-year Follow-up of the Changes in Anterior Segment After Phakic Collamer Lens Implantation. Am J Ophthalmol [Internet]. 2017;178:140–9. Available from: http://dx.doi.org/10.1016/j.ajo.2017.03.020spa
dc.source.bibliographicCitationTian Y, Jiang HB, Jiang J, Wen D, Xia XB, Song WT, et al. Comparison of Implantable Collamer Lens Visian ICL V4 and ICL V4c for high myopia: A cohort study. Med (United States). 2017;96(25):1–5.spa
dc.source.bibliographicCitationEom Y, Kim DW, Ryu D, Kim JH, Yang SK, Song JS, et al. Ring-shaped dysphotopsia associated with posterior chamber phakic implantable collamer lenses with a central hole. Acta Ophthalmol. 2017;95(3):e170–8.spa
dc.source.bibliographicCitationTeng H, Zhang H. Comparison of Artisan iris-claw intraocular lens implantation and posterior chamber intraocular lens sulcus fixation for aphakic eyes. Int J Ophthalmol. 2014;7(2):283–7.spa
dc.source.bibliographicCitationRizk IM, El-khouly SE, Sewelam AM. Visual performance after implantation of two types of phakic foldable intraocular lenses for correction of high myopia. Int J Ophthalmol. 2019;spa
dc.source.bibliographicCitationMcAlinden C, Pesudovs K, Moore JE. The development of an instrument to measure quality of vision: The quality of vision (QoV) questionnaire. Investig Ophthalmol Vis Sci. 2010;51(11):5537–45.spa
dc.source.bibliographicCitationTian M, Chen X, Zhou X, Wang X, Miao H, Chen Y. Refractive outcomes and optical quality after implantation of posterior chamber phakic implantable collamer lens with a central hole (ICL V4c). BMC Ophthalmol. 2018;18(1):1–7.spa
dc.source.bibliographicCitationPeŕez-Vives C, Ferrer-Blasco T, Madrid-Costa D, Garciá-Lázaro S, Monteś-Micó R. Visual quality comparison of conventional and Hole-Visian implantable collamer lens at different degrees of decentering. Br J Ophthalmol. 2014;98(1):59–64.spa
dc.source.bibliographicCitationUozato H, Shimizu K, Kawamorita T, Ohmoto F. Modulation transfer function of intraocular collamer lens with a central artificial hole. Graefe’s Arch Clin Exp Ophthalmol. 2011;249(7):1081–5.spa
dc.source.bibliographicCitationIeong A, Hau SCH, Rubin GS, Allan BDS. Quality of life in high myopia before and after implantable Collamer lens implantation. Ophthalmology [Internet]. 2010;117(12):2295–300. Available from: http://dx.doi.org/10.1016/j.ophtha.2010.03.055spa
dc.thesis.levelEspecializaciónspa
dc.thesis.disciplineMedicina y Ciencias de la Salud - Oftalmologíaspa
dc.type.dcmi-type-vocabularyTextspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadasspa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/2.5/co/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/2.5/co/